Drugs · acquisition-cost intelligence
Prograf
Tacrolimus· ingredient tacrolimusAgents for dermatitis, excluding corticosteroids· TACROLIMUS 1 mg/1; TACROLIMUS .2 mg/1; TACROLIMUS .5 mg/1; TACROLIMUS 5 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$6.19
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 8 weeks.
2025-01-222026-05-20
Same-ingredient options by acquisition cost
Other tacrolimus products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| tacrolimus | $0.16131 | −$6.03 |
| Tacrolimus | $0.16131 | −$6.03 |
| Tacrolimus | $0.41056 | −$5.78 |
| tacrolimus | $0.89046 | −$5.30 |
| Tacrolimus | $0.89863 | −$5.29 |
Medicare Part D coverage · CY2026
On 7 plan formularies · typical tier 4
Prior auth 100% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.